In order to access this content you must be logged in and have a subscription to PL Intelligence.
PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
GLAXOSMITHKLINE EXERCISES OPTION TO HUMAN GENOME SCIENCES' TRAIL RECEPTOR ANTIBODY
Genome Therapeutics joins full-scale effort to sequence the human genome
Genome Therapeutics reaches milestone in asthma research
Amgen pays Genome Therapeutics for research milestone
Genome Therapeutics and MerLion establish drug discovery collaboration
PanTherix enters agreement with Genome Therapeutics
Genome Therapeutics and Amgen conclude research agreement
Genome Therapeutics announces milestones in asthma collaboration
Genome Therapeutics and bioMerieux form alliance
Genome Therapeutics and ICAgen collaborate to conduct drug target analysis
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
